Diagnosis and treatment of diseases may soon become less expensive. In a move to bring expensive medical devices such as stents, catheters, orthopaedic implants and heart valves under the price negotiation, the government has asked the National Pharmaceutical Pricing Authority (NPPA) to collect data on price, supply and availability of medical devices in the country. The government is understood to have told the price regulator to examine pricing of medical devices in the country vis-a-vis other countries having similar purchasing power. It is learnt that the government is in the process of framing guidelines for compulsory price negotiation with companies for their new products



Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

Related Health Policy


whatsapp--v1